STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
35 hedge funds and large institutions have $3.32M invested in Statera Biopharma, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
93% less call options, than puts
Call options by funds: $1K | Put options by funds: $14K
Holders
35
Holding in Top 10
–
Calls
$1K
Puts
$14K
Top Buyers
| 1 | +$1.24M | |
| 2 | +$17K | |
| 3 | +$12K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$10.8K |
| 5 |
Citigroup
New York
|
+$6.45K |
Top Sellers
| 1 | -$750K | |
| 2 | -$656K | |
| 3 | -$184K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$135K |
| 5 |
Renaissance Technologies
New York
|
-$26.9K |